Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.52 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.52 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.52 |
| ▸ | KCNK3 | O14649 | 2/20 | 0.47 |
| ▸ | KCNK5 | O95279 | 1/20 | 0.47 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.47 |
| ▸ | KCNK17 | Q96T54 | 1/20 | 0.47 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.45 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.44 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.44 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.44 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.43 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.43 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.43 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5405814 | 0.92 | CHRNB2 (0.51) | PTPN1CHRNB2CHRNA4KCNK3KCNK5 | |
| SCHEMBL5397222 | 0.92 | CHRNB2 (0.53) | PTPN1CHRNB2CHRNA4KCNK3KCNK5 | |
| SCHEMBL5412093 | 0.92 | RAB9A (0.56) | PTPN1CHRNB2CHRNA4KCNK3KCNK5 | |
| SCHEMBL5397438 | 0.92 | CHRNB2 (0.50) | PTPN1CHRNB2CHRNA4FFAR1AKR1B1 | |
| SCHEMBL5394163 | 0.91 | CHRNB2 (0.59) | CHRNB2CHRNA4KCNA5RAB9AHPGD | |
| SCHEMBL5406368 | 0.90 | CHRNB2 (0.54) | PTPN1CHRNB2CHRNA4HPGDMCL1 | |
| SCHEMBL5399048 | 0.90 | ALDH1A1 (0.52) | RAB9AHPGDSLC6A5FFAR1TAS1R3 | |
| SCHEMBL5402499 | 0.89 | ALDH1A1 (0.54) | CHRNB2CHRNA4RAB9AHPGDSLC6A5 | |
| SCHEMBL5398082 | 0.89 | ALDH1A1 (0.54) | CHRNB2CHRNA4RAB9AHPGDSLC6A5 | |
| SCHEMBL5403362 | 0.89 | KMT2A (0.55) | CHRNB2CHRNA4RAB9AMEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7285680-B2 | β-alanine derivatives and the use thereof | ONO PHARMACEUTICAL CO., LTD. (JP) | 2007-10-23 | — | — | US | disclosed |
| US-20050256160-A1 | Beta-alanine derivatives and the use thereof | ONO PHARMACEUTICAL CO., LTD. (JP) | 2005-11-17 | — | — | US | disclosed |
| EP-1533294-A1 | BETA-ALANINE DERIVATIVE AND USE THEREOF | ONO PHARMACEUTICAL CO., LTD. (JP) | 2005-05-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050256160-A1 | Beta-alanine derivatives and the use thereof | TGFB1, PML, APOB | PTPN1 2998/4885CHRNB2 857/4885CHRNA4 1750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.